Discover why Medis is the company
that leads the way into the future
Hans Brons (CEO)
Hans joined Medis in 2019 as CEO. He brings over 28 years of business and general management experience in technology-focused companies of both corporate, start-up and scale-up sizes. Prior to Medis he led Nemo Healthcare and was (co-)founder of several technology-focused companies. He held several senior and general management positions at Philips Electronics, including Philips Healthcare.
Hans gets intrigued by disruptive technology and leading the transformation from new technology into marketable products and sustainable competitive advantage.
Johan (Hans) HC Reiber (CSO)
Johan (Hans) HC Reiber is co-founder (1989) and former CEO of Medis. He is also founder of the Division of Image Processing (LKEB), initially at the Thoraxcenter in Rotterdam in 1976 and from 1990 at the Leiden University Medical center (LUMC). He is emeritus professor for cardiovascular imaging both at the LUMC and the Interuniversity Cardiology Institute of the Netherlands (ICIN), and member of the Royal Netherlands Academy of Arts and Sciences (KNAW). Hans’ ambition has always been to bring innovative image-based quantitation applications into the hands of the clinician and clinical researcher worldwide. After having served 10 years as CEO of Medis, Hans now serves as Chief Scientific Officer responsible for the Applied Research and he is the primary point-of-contact for internal and external clinical research trials.
Peter Rutjes (CCO)
Peter Rutjes joined Medis in December 2018 as CCO. He brings over 20 years Sales & General management to Medis. Peter has a demonstrated history of successful working in the hospital & health care industry. Skilled in Medical Devices and HC IT. Prior to Medis he led 6 years a Medical device distributor and had (general) management positions in GE Healthcare, Dell and McKesson. Peter has a nursing background and studied also nursing informatics. Peter has a strong customer, financial- and operational focus and likes (new) business development. He strongly believes in partnering with customers, customer intimacy and teamwork.
Bob Goedhart (VP R&D)
Bob Goedhart is the Vice President R&D of Medis Medical Imaging Systems. He is with Medis for 20 years, worked on the products as a researcher, software engineer and project manager at first, and being responsible for product development over the last 15 years. Further, he is responsible for Quality Assurance and Regulatory Affairs within the company.
Bob holds MSc and PhD degrees from Delft University of Technology, and has been working as a post-doc at TU Delft for several years. During this time, he participated in several EU projects in the information technology program (called ESPRIT at the time), in which he worked on the development of AI techniques and application thereof in an industrial environment.
Daniel Garcia Miranda (VP Global Sales)
Daniel Garcia Miranda is the VP Global Sales in Medis and has served in different positions in the Marketing and Sales department, and became the corporate VP Marketing and Sales in 2008. Daniel has built up a worldwide network of commercial partners and clinical key-opinion-leaders, contributing to the worldwide success of Medis. Under Daniel’s guidance Medis has successfully retained key geographical markets such as EU, Japan and USA and helped Medis, and her worldwide commercial partners, to identify, secure and maintain new commercial channels and business models for Medis products. More recently Daniel has helped in expanding the commercial activities in territories such as ASEANA, China, Middle East, India, Russia and LATAM.
Carl J.G. Evertsz
Before joining Medis’ supervisory board in 2018, Carl Evertsz consulted Medis in the areas of business and corporate development and corporate finance. Carl has extensive experience founding, leading, and growing innovative medical imaging companies. He actively led international business, corporate and R&D developments, including M&A and technology acquisitions. Amongst others, he was CEO of MeVis Medical Solutions AG, which he led through a successful IPO in 2007, and CEO of MeVis BreastCare, a joint-venture with Siemens founded in 2001. As business angel he served 4 years at SCiLS GmbH as chairman of the advisory board and since 2014 at ScreenPoint Medical B.V. as a non-executive member of the board of directors.
Nicky joined Medis’ supervisory board as a representative of Van Herk Investments in February 2018. Nicky has over 10 years’ experience in a diverse range of international business development- and investment positions in the life sciences and brings experience in the establishment of (public-private) partnerships, the commercialization of medical innovations and technologies, (out)licensing, deal making, spin-off creation and intellectual property management. In addition to her role at Medis, Nicky is the Executive Vice President Global Business Development at SkylineDx, a commercial-stage diagnostics company, Fund Manager for Swanbridge Capital, a Rotterdam-based venture capital firm that funds early stage start-up companies in the life sciences, and supervisory board member at IPaDiC B.V., a start-up company developing an implantable insulin pump.
The official start of the Medis Medical Imaging Systems bv company was in 1989 in Leiden, as a spin-off from the Leiden University Medical Center (LUMC), The Netherlands, but actually based already on 15 years of imaging research experience from the Thoraxcenter at the Erasmus University in Rotterdam. The initial work concentrated on creating a commercial version of the QCA (Quantitative Coronary Angiography) application under the name of QCA-CMS (now QAngio XA), the gold standard post-processing software solution for quantitative coronary and left ventricular analysis.
In the early 90’s, the developments expanded towards cardiovascular MR with quantitative solutions for LV function and flow all based on image segmentation techniques, followed by intravascular imaging with IVUS and later OCT, as well as CT for function and coronary plaque burden assessment.
Since the early 2010’s, Medis has also concentrated on innovative solutions for the physiologic assessment of coronary arteries in interventional cardiology, all image-based without a pressure wire and without a drug stimulus. Medis is dedicated to continuously expand the features of all these solutions, where robustness, accuracy and reproducibility are key to its success. These developments are supported by a number of strategic partners.
Medis has been very fortunate that it has established an enormous network of loyal clinical researchers and key opinion leaders around the globe, who provide excellent feedback and scientific publications on early research versions, that are later transferred into clinical solutions with all the necessary regulatory approvals and worldwide services.
For more than 30 years now cardiologists, radiologists, researchers and industry partners worldwide rely on Medis post-processing software, resulting in our installed base of customers in over 40 countries.
Medis headquarters is in Leiden, The Netherlands, but over the years we have established subsidiaries and branch offices in the USA, Japan, United Kingdom, as well as distibutors and local agents in multiple countries.
We believe in empowering medical professionals by continuously innovating the latest cutting-edge technology and integrating these in our analytical solutions.
Our team of professionals take great pride in developing software that gives clinicians and clinical researchers the confidence that they seek. Our goal is to find, develop and support solutions. We come from a history of post-processing cardiovascular imaging. We research to provide technology that captures and quantifies detailed imaging aspects.
« We are committed to improving the diagnosis of cardiovascular imaging and support the subsequent treatment strategies for patients worldwide. »
Providing innovation-driven cardiovascular imaging solutions based on technology and experience. Our high-quality quantification software empowers medical professionals with solutions that support their diagnoses and treatment options.
We aim to adapt to the ever changing cardiovascular imaging environment in order to be flexible enough to find solutions to new challenges. At Medis we strive to constantly provide medical professionals with support worldwide, so that together we can improve patient’s quality of care.